SENIOR trial demonstrates efficacy of insulin glargine 300 in older adults with type 2 diabetes


eMediNexus    23 July 2018

Results from the SENIOR trial published in the August 2018 issue of the journal Diabetes Care demonstrate the efficacy and safety of insulin glargine 300 Units/mL in adults aged 65 years and older with type 2 diabetes compared to insulin glargine 100 Units/mL. Comparable reductions in A1c and reduced risk of symptomatic hypoglycemic episodes were also observed with insulin glargine 300 units.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.